Bharangin, a Diterpenoid Quinonemethide, Abolishes Constitutive and Inducible Nuclear Factor-κB (NF-κB) Activation by Modifying p65 on Cysteine 38 Residue and Reducing Inhibitor of Nuclear Factor-κB α Kinase Activation, Leading to Suppression of NF-κB-Regulated Gene Expression and Sensitization of Tumor Cells to Chemotherapeutic Agents

Subash C. Gupta(All India Institute of Medical Sciences Guwahati), Bharat B. Aggarwal(Max Super Speciality Hospital), Ramaswamy Kannappan(University of Alabama at Birmingham), Sajin K. Francis, Jihye Kim(Gwangju Health University), Ghazi M. Rahman(University of Houston), Joydip Das(American Pharmacists Association), Mangalam S. Nair, Reshma Raveendran
Molecular Pharmacology
July 28, 2011
Cited by 34


Related Papers